LAL

RxSight, Inc. to Present at the Bank of America Healthcare Conference

Retrieved on: 
Friday, April 22, 2022
NASDAQ, Interest, Visual acuity, GLOBE, Patient, Conference, Technology, Bank, LAL, IOL, Health insurance

ALISO VIEJO, Calif., April 22, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced plans to participate in the upcoming Bank of America Healthcare Conference.

Key Points: 
  • ALISO VIEJO, Calif., April 22, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced plans to participate in the upcoming Bank of America Healthcare Conference.
  • RxSights management is scheduled to present Tuesday, May 10, 2022, at 12:00pm PT / 3:00pm ET.
  • Interested parties may access a live and archived webcast of the presentation on the Investors section of the companys website at: https://investors.rxsight.com/ .
  • RxSight, Inc. is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery.

RxSight, Inc. to Report First Quarter 2022 Financial Results on May 5, 2022 

Retrieved on: 
Thursday, April 21, 2022
NASDAQ, International, Visual acuity, News, GLOBE, Patient, Technology, LAL, IOL, Investor, Pharmaceutical industry

ALISO VIEJO, Calif., April 21, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) April 21, 2022 RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced that it will report financial results for the first quarter 2022 after the market close on Thursday, May 5, 2022.

Key Points: 
  • ALISO VIEJO, Calif., April 21, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) April 21, 2022 RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced that it will report financial results for the first quarter 2022 after the market close on Thursday, May 5, 2022.
  • The companys management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
  • RxSight, Inc. is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery.
  • The LAL now features ActivShield technology, a revolutionary UV protection layer built into the lens.

Surgeon Presentations to Highlight RxSight® Light Adjustable Lens System at Upcoming American Society of Cataract and Refractive Surgery Annual Meeting

Retrieved on: 
Tuesday, April 19, 2022
LDD, Society, Biometrics, ASCRS, Poster, Intraocular lens, NASDAQ, Visual acuity, Ultraviolet, GLOBE, Semipermeable membrane, Terminology, Surgeon, Technology, Case series, American Society of Cataract and Refractive Surgery, Cataract, EDT, LAL, Refractive surgery, IOL, Radial keratotomy, Level 1, Telescopic sight, Medical device, Risk management, Patient, MD

Descemet Membrane Endothelial Keratoplasty Combined with Implantation of Light Adjustable Lens.

Key Points: 
  • Descemet Membrane Endothelial Keratoplasty Combined with Implantation of Light Adjustable Lens.
  • Intraocular Lens Position of Light Adjustable Lens and Biometric Changes: 1-Year Follow-up.
  • Light Adjustable Intraocular Lens in Patients with Radial Keratotomy Undergoing Cataract Surgery: A Case Series.
  • The RxSight Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens (LAL), RxSight Light Delivery Device (LDD) and accessories, is the first and only commercially available intraocular lens (IOL) technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery.

RxSight, Inc. to Present at the Needham Virtual Healthcare Conference

Retrieved on: 
Monday, March 28, 2022
IOL, NASDAQ, Interest, Conference, LAL, Visual acuity, Technology, GLOBE, Patient, Health insurance

ALISO VIEJO, Calif., March 28, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) --RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced plans to participate in the upcoming Needham Virtual Healthcare Conference.

Key Points: 
  • ALISO VIEJO, Calif., March 28, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) --RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced plans to participate in the upcoming Needham Virtual Healthcare Conference.
  • RxSights management is scheduled to present Monday, April 11, 2022, at 12:45pm PT / 3:45pm ET.
  • Interested parties may access a live and archived webcast of the presentation on the Investors section of the companys website at: https://investors.rxsight.com/ .
  • RxSight, Inc. is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery.

RxSight, Inc. Reports Fourth Quarter and Fiscal Year 2021 Financial Results

Retrieved on: 
Tuesday, March 8, 2022
NASDAQ, International, IPO, Company, Carolwood Pacific Railroad, Annual general meeting, Visual acuity, IOL, Investment, Adoption, LDD, Shareholder, GLOBE, Patient, NUALS Arts and Literary Annual Meet, Technology, MCI Inc., Growth, CEO, Achieved, Terminology, LAL, Video game, Pharmaceutical industry, Film, Reinsurance, Animal

In the fourth quarter of 2021, total revenue was $8.4 million, an increase of 71% compared to the fourth quarter of 2020 and 46% growth over the prior quarter ended September 30, 2021.

Key Points: 
  • In the fourth quarter of 2021, total revenue was $8.4 million, an increase of 71% compared to the fourth quarter of 2020 and 46% growth over the prior quarter ended September 30, 2021.
  • Gross profit for the fourth quarter of 2021 was $2.9 million, or 34% of revenue compared to gross profit of $1.4 million, or 28% for the fourth quarter of 2020.
  • Total operating expenses for the fourth quarter of 2021 were $17.5 million, an 81% increase from $9.7 million in the fourth quarter of 2020.
  • On Tuesday, March 8, 2022, at 1:30 p.m. Pacific Time, the company will host a conference call to discuss its fourth quarter and fiscal year 2021 financial results.

RxSight, Inc. to Report Fourth Quarter and Fiscal Year 2021 Financial Results on March 8, 2022

Retrieved on: 
Wednesday, February 23, 2022
GLOBE, Investor, News, International, LAL, NASDAQ, IOL, Visual acuity, Patient, Technology, Pharmaceutical industry

ALISO VIEJO, Calif., Feb. 23, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced that it will report financial results for the fourth quarter and fiscal year 2021 after the market close on Tuesday, March 8, 2022.

Key Points: 
  • ALISO VIEJO, Calif., Feb. 23, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced that it will report financial results for the fourth quarter and fiscal year 2021 after the market close on Tuesday, March 8, 2022.
  • The companys management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
  • RxSight, Inc. is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery.
  • The LAL now features ActivShield technology, a revolutionary UV protection layer built into the lens.

RxSight, Inc. to Present at the SVB Leerink Global Healthcare Conference

Retrieved on: 
Thursday, February 3, 2022
Patient, Interest, Technology, LAL, IOL, Visual acuity, GLOBE, Conference, Health insurance

ALISO VIEJO, Calif., Feb. 03, 2022 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced plans to participate in the upcoming virtual SVB Leerink Global Healthcare Conference.

Key Points: 
  • ALISO VIEJO, Calif., Feb. 03, 2022 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced plans to participate in the upcoming virtual SVB Leerink Global Healthcare Conference.
  • RxSights management is scheduled to participate in a fireside chat Thursday, February 17, 2022, at 12:40pm PT / 3:40pm ET.
  • Interested parties may access a live and archived webcast of the presentation on the Investors section of the companys website at: https://investors.rxsight.com/ .
  • RxSight, Inc. is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery.

RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full Year 2021 Financial and Operational Results

Retrieved on: 
Sunday, January 9, 2022
LAL, Growth, Forward-looking statement, Patient, Mission statement, U.S. Securities and Exchange Commission, Security (finance), CEO, Awareness, NASDAQ, SEC, LDD, Adoption, GLOBE, Terminology, Technology, IOL, Visual acuity, Investment, Audit

The Companys fourth quarter and full year 2021 financial results are preliminary and are subject to the completion of the Companys 2021 audit.

Key Points: 
  • The Companys fourth quarter and full year 2021 financial results are preliminary and are subject to the completion of the Companys 2021 audit.
  • Audited fourth quarter and full year 2021 financial results will be announced in early March.
  • This press release contains forward-looking statements, including statements concerning our preliminary unaudited fourth quarter and fiscal 2021 financial and operational results and anticipated continued growth in 2022.
  • You should carefully review our audited, consolidated financial statements for the year ended December 31, 2021 when they become available.

RxSight to Present at the J.P. Morgan Healthcare Conference

Retrieved on: 
Tuesday, December 28, 2021
IOL, GLOBE, Interest, NASDAQ, LAL, Conference, Patient, Visual acuity, Technology, Health insurance

ALISO VIEJO, Calif., Dec. 28, 2021 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST), an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced plans to participate in the upcoming virtual J.P. Morgan Healthcare Conference.

Key Points: 
  • ALISO VIEJO, Calif., Dec. 28, 2021 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST), an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced plans to participate in the upcoming virtual J.P. Morgan Healthcare Conference.
  • RxSight management is scheduled to present Thursday, January 13, 2022, at 6:45am PT / 9:45am ET.
  • RxSight, Inc. is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery.
  • The RxSight Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens (LAL), RxSight Light Delivery Device (LDD) and accessories, is the first and only commercially available intraocular lens (IOL) technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery.

RxSight to Participate in the Ophthalmology Day at BTIG

Retrieved on: 
Thursday, November 18, 2021
IOL, Patient, Visual acuity, Technology, Interest, LAL, GLOBE, NASDAQ, Ophthalmology, Health insurance

ALISO VIEJO, Calif., Nov. 18, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced plans to participate in the upcoming virtual Ophthalmology Day at BTIG.

Key Points: 
  • ALISO VIEJO, Calif., Nov. 18, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced plans to participate in the upcoming virtual Ophthalmology Day at BTIG.
  • RxSights management is scheduled to participate in a fireside chat Tuesday, November 30, 2021, at 8:30am PT / 11:30am ET.
  • RxSight, Inc. is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery.
  • The RxSight Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens (LAL), RxSight Light Delivery Device (LDD) and accessories, is the first and only commercially available intraocular lens (IOL) technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery.